Skip to content
PH-HE05

Haemophilia

How factors VIII and IX amplify thrombin to build a stable clot, why their lack lets a platelet plug form but fail, why bleeding goes into joints and muscles, and how the X-linked inheritance shapes who is affected.

By the end, you can

  • Describe primary and secondary haemostasis and the role of factors VIII and IX.
  • Explain why haemophilia causes delayed, prolonged bleeding rather than immediate bleeding from small cuts.
  • Relate severity to the factor level and explain the X-linked inheritance.
  • Explain how repeated joint bleeding damages the joint.
  • Interpret the pattern of a prolonged APTT with a normal PT and platelet count.
  • Recognise the joint pathology, severity bands and tests of haemophilia, and explain how factor replacement, non-factor therapies and supporting medicines act on its mechanism.

What it is

Haemophilia is an inherited bleeding disorder caused by deficiency of a clotting factor: factor VIII in haemophilia A and factor IX in haemophilia B. Both genes are on the X chromosome, so the condition mainly affects males. Severity depends on how much factor activity remains.

3 types to tell apart
Haemophilia A
Factor VIII deficiency, about four in five cases.
Haemophilia B
Factor IX deficiency; clinically indistinguishable without measuring the factor.
Severity
Severe below 1% of normal activity (bleeding into joints without injury), moderate 1–5%, mild above 5% (bleeding mainly after injury or surgery).

US spelling: haemophilia → hemophilia, haemostasis → hemostasis.

Normal function

How a clot forms and holds

When a vessel is injured, it constricts and platelets stick to exposed collagen, change shape and clump together into a plug. This primary haemostasis stops bleeding from small cuts within minutes, but the plug is fragile.

Secondary haemostasis builds a mesh of fibrin through the plug. Tissue factor from the damaged vessel wall starts the process with factor VII, producing a small amount of thrombin. That first thrombin activates platelets and factors V, VIII and XI.

On the platelet surface, activated factor IX with its cofactor factor VIII converts factor X to its active form far faster than tissue factor alone. This amplification produces the large burst of thrombin that turns fibrinogen into enough fibrin to hold the clot together.